Egl nine homolog 1 — Drug Target

5 drugs 5 marketed

All drugs that target Egl nine homolog 1 — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Vitamin C [EPC] · Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]

Marketed (5)

Musredo · BAYER YAKUHIN, Ltd · Hematology
Allomaleic Acid · Vitamin C [EPC] · Immunology
Enaroy · Japan Tabacco · Hematology
Jesduvroq · GSK · Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] · Hematology
Jesduvroq works by activating hypoxia-inducible factor prolyl hydroxylase inhibitors, which increases the production of erythropoietin, a hormone that stimulates red blood cell production.
Butanedioic Acid · Vitamin C [EPC] · Hematology